{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:30:23Z","timestamp":1790314223202,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005669","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Estado da Para\u00edba","doi-asserted-by":"publisher","award":["2023\/1977"],"award-info":[{"award-number":["2023\/1977"]}],"id":[{"id":"10.13039\/501100005669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005669","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Estado da Para\u00edba","doi-asserted-by":"publisher","award":["642\/2024"],"award-info":[{"award-number":["642\/2024"]}],"id":[{"id":"10.13039\/501100005669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s13346-025-01878-w","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T12:02:29Z","timestamp":1748433749000},"page":"4742-4760","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ureasil-polyether hybrid polymer-based vaginal ovules for combination therapy in the treatment of vulvovaginal candidiasis"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2610-3668","authenticated-orcid":false,"given":"Brenda Maria Silva","family":"Bezerra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaidy G.","family":"Orellana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2901-9660","authenticated-orcid":false,"given":"Karina Guimar\u00e3es","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4729-9970","authenticated-orcid":false,"given":"Emmanuel A.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7247-1598","authenticated-orcid":false,"given":"Jo\u00e3o Augusto","family":"Oshiro-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"issue":"7","key":"1878_CR1","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/jog.15267","volume":"48","author":"L Jafarzadeh","year":"2022","unstructured":"Jafarzadeh L, et al. Vulvovaginal candidiasis: an overview of mycological, clinical, and immunological aspects. J Obstet Gynaecol Res. 2022;48(7):1546\u201360.","journal-title":"J Obstet Gynaecol Res"},{"key":"1878_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.mycmed.2017.01.003","volume":"2","author":"L Mtibaa","year":"2017","unstructured":"Mtibaa L, et al. Vulvovaginal candidiasis: Etiology, symptomatology and risk factors. J Mycol Med. 2017;2:153\u20138.","journal-title":"J Mycol Med"},{"key":"1878_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-018-0607-z","volume":"18","author":"A Bitew","year":"2018","unstructured":"Bitew A, Abebaw Y. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern. BMC Womens Health. 2018;18:1\u201310.","journal-title":"BMC Womens Health"},{"issue":"6","key":"1878_CR4","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3109\/1040841X.2015.1091805","volume":"42","author":"B Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves B, et al. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016;42(6):905\u201327.","journal-title":"Crit Rev Microbiol"},{"issue":"1","key":"1878_CR5","first-page":"615958","volume":"2014","author":"SC Deorukhkar","year":"2014","unstructured":"Deorukhkar SC, et al. Non-albicans Candida infection: an emerging threat. Interdiscip Perspect Infect Dis. 2014;2014(1):615958.","journal-title":"Interdiscip Perspect Infect Dis"},{"issue":"3","key":"1878_CR6","doi-asserted-by":"publisher","first-page":"101278","DOI":"10.1016\/j.mycmed.2022.101278","volume":"32","author":"J Intra","year":"2022","unstructured":"Intra J, et al. Prevalence and species distribution of microorganisms isolated among non-pregnant women affected by vulvovaginal candidiasis: a retrospective study over a 20 year-period. J Mycol Med. 2022;32(3):101278.","journal-title":"J Mycol Med"},{"issue":"6","key":"1878_CR7","doi-asserted-by":"publisher","first-page":"e470","DOI":"10.1016\/S2666-5247(23)00067-8","volume":"4","author":"F Daneshnia","year":"2023","unstructured":"Daneshnia F, et al. Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap. The Lancet Microbe. 2023;4(6):e470\u201380.","journal-title":"The Lancet Microbe"},{"issue":"02","key":"1878_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1590\/1516-3180.2014.1322640","volume":"132","author":"L Gunther","year":"2014","unstructured":"Gunther L, et al. Prevalence of Candida albicans and non-albicans isolates from vaginal secretions: comparative evaluation of colonization, vaginal candidiasis and recurrent vaginal candidiasis in diabetic and non-diabetic women. Sao Paulo Med J. 2014;132(02):116\u201320.","journal-title":"Sao Paulo Med J"},{"issue":"4","key":"1878_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41579-023-00861-x","volume":"21","author":"MC Fisher","year":"2023","unstructured":"Fisher MC, Denning DW. The WHO fungal priority pathogens list as a game-changer. Nat Rev Microbiol. 2023;21(4):211\u20132.","journal-title":"Nat Rev Microbiol"},{"key":"1878_CR10","unstructured":"Organization WH. WHO fungal priority pathogens list to guide research, development and public health action. In: World Health Organization. 2022. Available at: https:\/\/www.who.int\/publications\/i\/item\/9789240060241. Accessed 7 Apr 2025."},{"issue":"2","key":"1878_CR11","doi-asserted-by":"publisher","first-page":"e00021","DOI":"10.1128\/mmbr.00021-23","volume":"88","author":"M Katsipoulaki","year":"2024","unstructured":"Katsipoulaki M, et al. Candida albicans and Candida glabrata: global priority pathogens. Microbiol Mol Biol Rev. 2024;88(2):e00021-23.","journal-title":"Microbiol Mol Biol Rev"},{"key":"1878_CR12","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","volume":"7","author":"SG Whaley","year":"2017","unstructured":"Whaley SG, et al. Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Front Microbiol. 2017;7:2173.","journal-title":"Front Microbiol"},{"key":"1878_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.mib.2020.05.012","volume":"57","author":"GJ Sullivan","year":"2020","unstructured":"Sullivan GJ, Delgado NN, Maharjan R, Cain AK. How antibiotics work together: molecular mechanisms behind combination therapy. Curr Microbiol. 2020;57:31\u201340.","journal-title":"Curr Microbiol"},{"key":"1878_CR14","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.3390\/molecules25215114","volume":"25","author":"WH Lo","year":"2020","unstructured":"Lo WH, Deng FS, Chang CJ, Lin CH. Synergistic antifungal activity of chitosan with fluconazole against Candida albicans, Candida tropicalis, and fluconazole-resistant strains. Molecules. 2020;25:5114.","journal-title":"Molecules"},{"issue":"6","key":"1878_CR15","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/lam.13458","volume":"72","author":"J Wang","year":"2021","unstructured":"Wang J, et al. The synergistic antifungal activity of resveratrol with azoles against Candida albicans. Lett Appl Microbiol. 2021;72(6):688\u201397.","journal-title":"Lett Appl Microbiol"},{"key":"1878_CR16","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.2147\/IDR.S305503","volume":"14","author":"A Khan","year":"2021","unstructured":"Khan A, et al. Coadministration of ginger extract and fluconazole shows a synergistic effect in the treatment of drug-resistant vulvovaginal candidiasis. Infect Drug Resist. 2021;14:1585\u201399.","journal-title":"Infect Drug Resist"},{"key":"1878_CR17","doi-asserted-by":"publisher","first-page":"110580","DOI":"10.1016\/j.biopha.2020.110580","volume":"130","author":"Y Liu","year":"2020","unstructured":"Liu Y, et al. The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation. Biomed Pharmacother. 2020;130:110580.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"1878_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2174\/1570163817666200518074629","volume":"18","author":"K Cheraghipour","year":"2021","unstructured":"Cheraghipour K, et al. Anti-Candida activity of curcumin: A systematic review. Curr Drug Discov Technol. 2021;18(3):379\u201390.","journal-title":"Curr Drug Discov Technol"},{"issue":"5","key":"1878_CR19","first-page":"570","volume":"10","author":"M Sharma","year":"2010","unstructured":"Sharma M, Manoharlal R, Negi AS, Prasad R. Synergistic anticandidal activity of pure polyphenol curcumin I in combination with azoles and polyenes generates reactive oxygen species leading to apoptosis. FEMS Yeast Res. 2010;10(5):570\u20138.","journal-title":"FEMS Yeast Res"},{"issue":"1","key":"1878_CR20","first-page":"2025557","volume":"2024","author":"UJ Tsopmene","year":"2024","unstructured":"Tsopmene UJ, Tokam Kuat\u00e9 CR, Kayoka-Kabongo PN, Bisso BN, Metopa A, Mofor CT, Dzoyem JP. Antibiofilm activity of curcumin and piperine and their synergistic effects with antifungals against Candida albicans clinical isolates. Scientifica. 2024;2024(1):2025557.","journal-title":"Scientifica"},{"key":"1878_CR21","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/pharmaceutics14051107","volume":"14","author":"KV Drozd","year":"2022","unstructured":"Drozd KV, Manin AN, Boycov DE, Perlovich GL. Simultaneous improvement of dissolution behavior and oral bioavailability of antifungal miconazole via cocrystal and salt formation. Pharmaceutics. 2022;14:1107.","journal-title":"Pharmaceutics"},{"key":"1878_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.tifs.2021.02.006","volume":"110","author":"S Sabet","year":"2021","unstructured":"Sabet S, Rashidinejad A, Melton LD, McGillivray DJ. Recent advances to improve curcumin oral bioavailability. Trends Food Sci Technol. 2021;110:253\u201366.","journal-title":"Trends Food Sci Technol"},{"key":"1878_CR23","doi-asserted-by":"publisher","first-page":"105397","DOI":"10.1016\/j.jddst.2024.105397","volume":"93","author":"Z Yang","year":"2024","unstructured":"Yang Z, et al. Vagina, a promising route for drug delivery. J Drug Deliv Sci Technol. 2024;93:105397.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1878_CR24","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/pharmaceutics16030312","volume":"16","author":"BMS Bezerra","year":"2024","unstructured":"Bezerra BMS, et al. The efficacy of hybrid vaginal ovules for co-delivery of curcumin and miconazole against Candida albicans. Pharmaceutics. 2024;16:312.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1878_CR25","first-page":"727324","volume":"2015","author":"JA Oshiro Junior","year":"2015","unstructured":"Oshiro Junior JA, et al. Development of cutaneous bioadhesive ureasil-polyether hybrid films. Int J Polym Sci. 2015;2015(1):727324.","journal-title":"Int J Polym Sci"},{"key":"1878_CR26","doi-asserted-by":"publisher","first-page":"111581","DOI":"10.1016\/j.msec.2020.111581","volume":"119","author":"GH Mariano","year":"2021","unstructured":"Mariano GH, et al. Characterization of novel human intragenic antimicrobial peptides, incorporation and release studies from ureasil-polyether hybrid matrix. Mater Sci Eng: C. 2021;119:111581.","journal-title":"Mater Sci Eng: C"},{"key":"1878_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.colsurfb.2012.06.009","volume":"101","author":"LK Souza","year":"2013","unstructured":"Souza LK, et al. Ureasil\u2013polyether hybrid film-forming materials. Colloids Surf, B. 2013;101:156\u201361.","journal-title":"Colloids Surf, B"},{"key":"1878_CR28","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3390\/pharmaceutics13050675","volume":"13","author":"KM Nicolau Costa","year":"2021","unstructured":"Nicolau Costa KM, et al. Curcumin-loaded micelles dispersed in ureasil-polyether materials for a novel sustained-release formulation. Pharmaceutics. 2021;13:675.","journal-title":"Pharmaceutics"},{"key":"1878_CR29","unstructured":"CLSI\u2014Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard, 4th ed. Wayne: CLSI document M27. 2017."},{"key":"1878_CR30","unstructured":"Pillai SK, Moellering RC, Eliopoulos GM. Antimicrobial combinations. In: Lorian V. Antibiotics in Laboratory Medicine. 5th ed. Lippincott Williams & Wilkins: Philadelphia, PA, USA. 2005:365\u2013435."},{"key":"1878_CR31","unstructured":"CLSI\u2014Clinical and Laboratory Standards Institute. Method for Antifungal Disk Diffusion Susceptibility Testing for Yeasts. Approved Standard, 3rd ed. Wayne: CLSI document M44. 2018."},{"key":"1878_CR32","unstructured":"CLSI\u2014Clinical and Laboratory Standard Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7, 10th ed. CLSI document M07-A10. Wayne: Clinical and Laboratory Standards Institute. 2015."},{"key":"1878_CR33","doi-asserted-by":"publisher","first-page":"7680","DOI":"10.1128\/AAC.01819-15","volume":"59","author":"YL Traore","year":"2015","unstructured":"Traore YL, Chen Y, Bernier A, Ho EA. Impact of hydroxychloroquine-loaded polyurethane intravaginal rings on lactobacilli. Antimicrob Agents Chemother. 2015;59:7680.","journal-title":"Antimicrob Agents Chemother."},{"key":"1878_CR34","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/s13346-022-01133-6","volume":"12","author":"Y Chen","year":"2022","unstructured":"Chen Y, et al. Fused deposition modeling three-dimensional printing of flexible polyurethane intravaginal rings with controlled tunable release profiles for multiple active drugs. Drug Deliv and Transl Res. 2022;12:906\u201324.","journal-title":"Drug Deliv and Transl Res"},{"key":"1878_CR35","unstructured":"ISO. Biological evaluation of medical devices\u2014part 5: test for in vitro cytotoxicity, International Standard. 1999. no. (ISO10993\u20135)."},{"key":"1878_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10971-021-05690-z","volume":"101","author":"LA Chiavacci","year":"2022","unstructured":"Chiavacci LA, et al. Control of the structure and of the release profile of biological active molecules from materials prepared via sol-gel. J Sol-Gel Sci Technol. 2022;101:71\u201386.","journal-title":"J Sol-Gel Sci Technol"},{"key":"1878_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10971-011-2465-0","volume":"59","author":"S Pandey","year":"2021","unstructured":"Pandey S, Mishra SB. Sol\u2013gel derived organic\u2013inorganic hybrid materials: synthesis, characterizations and applications. J Sol-Gel Sci Technol. 2021;59:73\u201394.","journal-title":"J Sol-Gel Sci Technol"},{"issue":"5","key":"1878_CR38","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1021\/acsabm.8b00798","volume":"2","author":"BB Caravieri","year":"2019","unstructured":"Caravieri BB, et al. Ureasil organic\u2013inorganic hybrid as a potential carrier for combined delivery of anti-inflammatory and anticancer drugs. ACS Appl Bio Mater. 2019;2(5):1875\u201383.","journal-title":"ACS Appl Bio Mater"},{"key":"1878_CR39","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.3390\/nano11061362","volume":"11","author":"JA Oshiro-Junior","year":"2021","unstructured":"Oshiro-Junior JA, et al. Nanostructural arrangements and surface morphology on ureasil-polyether films loaded with dexamethasone acetate. Nanomaterials. 2021;11:1362.","journal-title":"Nanomaterials"},{"key":"1878_CR40","doi-asserted-by":"publisher","first-page":"114859","DOI":"10.1016\/j.addr.2023.114859","volume":"198","author":"K Al-Litani","year":"2023","unstructured":"Al-Litani K, et al. 3D printed implantable drug delivery devices for women\u2019s health: formulation challenges and regulatory perspective. Adv Drug Deliv Rev. 2023;198:114859.","journal-title":"Adv Drug Deliv Rev"},{"key":"1878_CR41","doi-asserted-by":"publisher","first-page":"106501","DOI":"10.1016\/j.ejps.2023.106501","volume":"188","author":"S Teworte","year":"2023","unstructured":"Teworte S, et al. Mucoadhesive 3D printed vaginal ovules to treat endometriosis and fibrotic uterine diseases. Eur J Pharm Sci. 2023;188:106501.","journal-title":"Eur J Pharm Sci"},{"key":"1878_CR42","first-page":"100142","volume":"5","author":"E Utomo","year":"2023","unstructured":"Utomo E, et al. Development of 3D-printed vaginal devices containing metronidazole for alternative bacterial vaginosis treatment. Int J Pharm. 2023;5:100142.","journal-title":"Int J Pharm"},{"key":"1878_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4322\/2179-443X.0730","volume":"42","author":"JF Mendes","year":"2021","unstructured":"Mendes JF, et al. Synthesis of ureasil-polyether film forming materials by using environmentally friendly solvent. Rev Ci\u00eanc Farm B\u00e1sica Apl. 2021;42:1\u201310.","journal-title":"Rev Ci\u00eanc Farm B\u00e1sica Apl"},{"key":"1878_CR44","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s10971-020-05272-5","volume":"95","author":"SC Nunes","year":"2020","unstructured":"Nunes SC, et al. Di-urea cross-linked siloxane hybrid materials incorporating oligo(oxypropylene) and oligo(oxyethylene) chains. J Sol-Gel Sci Technol. 2020;95:620\u201334.","journal-title":"J Sol-Gel Sci Technol"},{"key":"1878_CR45","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s11694-021-01225-w","volume":"16","author":"R Paranthaman","year":"2022","unstructured":"Paranthaman R, Moses JA, Anandharamakrishnan C. Powder X-ray diffraction conditions for screening curcumin in turmeric powder. Food Measure. 2022;16:1105\u201313.","journal-title":"Food Measure"},{"issue":"11","key":"1878_CR46","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1111\/1750-3841.15489","volume":"85","author":"JY Yu","year":"2020","unstructured":"Yu JY, et al. Preparation and characterization of curcumin solid dispersion using HPMC. J Food Sci. 2020;85(11):3866\u201373.","journal-title":"J Food Sci"},{"issue":"2","key":"1878_CR47","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ijpharm.2011.09.034","volume":"421","author":"S Tsutsumi","year":"2011","unstructured":"Tsutsumi S, et al. Characterization and evaluation of miconazole salts and cocrystals for improved physicochemical properties. Int J Pharm. 2011;421(2):230\u20136.","journal-title":"Int J Pharm"},{"key":"1878_CR48","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1039\/D4PM00042K","volume":"1","author":"MS Arshad","year":"2024","unstructured":"Arshad MS, et al. Fabrication of miconazole nitrate solid lipid nanoparticle loaded microneedle patches for the treatment of Candida albicans biofilms. RSC Pharmaceutics. 2024;1:458\u201371.","journal-title":"RSC Pharmaceutics"},{"key":"1878_CR49","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.gca.2017.06.010","volume":"212","author":"L Briese","year":"2017","unstructured":"Briese L, Arvidson RS, Luttge A. The effect of crystal size variation on the rate of dissolution\u2013A kinetic Monte Carlo study. Geochim Cosmochim Acta. 2017;212:167\u201375.","journal-title":"Geochim Cosmochim Acta"},{"issue":"6","key":"1878_CR50","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1039\/C3PY01126G","volume":"5","author":"EF Molina","year":"2014","unstructured":"Molina EF, et al. Fine-tuning of a nanostructure, swelling, and drug delivery profile by blending ureasil\u2013PEO and ureasil\u2013PPO hybrids. Polym Chem. 2014;5(6):1897\u2013904.","journal-title":"Polym Chem"},{"key":"1878_CR51","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/pharmaceutics14051027","volume":"14","author":"RM Barros","year":"2022","unstructured":"Barros RM, et al. Dexamethasone-loaded ureasil hydrophobic membrane for bone guided regeneration. Pharmaceutics. 2022;14:1027.","journal-title":"Pharmaceutics"},{"issue":"3","key":"1878_CR52","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1021\/cm801899u","volume":"21","author":"CV Santilli","year":"2009","unstructured":"Santilli CV, et al. Controlled drug release from ureasil\u2212polyether hybrid materials. Chem Mater. 2009;21(3):463\u20137.","journal-title":"Chem Mater"},{"issue":"2","key":"1878_CR53","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2478\/amma-2018-0012","volume":"64","author":"H Kelemen","year":"2018","unstructured":"Kelemen H, et al. Characterization of inclusion complexes between miconazole and different cyclodextrin derivatives. Acta Marisiensis Ser Medica. 2018;64(2):70\u20136.","journal-title":"Acta Marisiensis Ser Medica"},{"key":"1878_CR54","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ejmech.2018.12.016","volume":"163","author":"B Salehi","year":"2019","unstructured":"Salehi B, et al. The therapeutic potential of curcumin: A review of clinical trials. Eur J Med Chem. 2019;163:527\u201345.","journal-title":"Eur J Med Chem"},{"issue":"9","key":"1878_CR55","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1016\/j.xphs.2015.10.008","volume":"105","author":"S Baghel","year":"2016","unstructured":"Baghel S, Cathcart H, O\u2019Reilly NJ. Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs. J Pharm Sci. 2016;105(9):2527\u201344.","journal-title":"J Pharm Sci"},{"key":"1878_CR56","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/978-3-031-20298-8_19","volume-title":"Practical pharmaceutics: an international guideline for the preparation, care and use of medicinal products","author":"H Woerdenbag","year":"2023","unstructured":"Woerdenbag H, Visser JC, Kauss T, Sznitowska M. Rectal and vaginal. In: Le Brun P, Crauste-Manciet S, Kr\u00e4mer I, Smith J, Woerdenbag H, editors. Practical pharmaceutics: an international guideline for the preparation, care and use of medicinal products. Cham: Springer International Publishing; 2023. p. 405\u201337."},{"key":"1878_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11908-016-0554-5","volume":"18","author":"SG Whaley","year":"2016","unstructured":"Whaley SG, Rogers PD. Azole resistance in Candida glabrata. Curr Infect Dis Rep. 2016;18:1\u201310.","journal-title":"Curr Infect Dis Rep"},{"issue":"1","key":"1878_CR58","first-page":"8952878","volume":"2017","author":"MHG Figueiredo-Carvalho","year":"2017","unstructured":"Figueiredo-Carvalho MHG, et al. Relationship between the antifungal susceptibility profile and the production of virulence-related hydrolytic enzymes in Brazilian clinical strains of Candida glabrata. Mediators Inflamm. 2017;2017(1):8952878.","journal-title":"Mediators Inflamm"},{"issue":"3","key":"1878_CR59","doi-asserted-by":"publisher","first-page":"e00149","DOI":"10.1002\/prp2.149","volume":"3","author":"J Foucquier","year":"2015","unstructured":"Foucquier J, Guedj M. Analysis of drug combinations: current methodological landscape. Pharmacol Res Perspect. 2015;3(3):e00149.","journal-title":"Pharmacol Res Perspect"},{"issue":"3","key":"1878_CR60","first-page":"3","volume":"8","author":"SM Tsao","year":"2000","unstructured":"Tsao SM, Yin MC. Enhanced inhibitory effect from interaction of curcumin with amphotericin B or fluconazole against Candida species. J Food Drug Anal. 2000;8(3):3.","journal-title":"J Food Drug Anal"},{"key":"1878_CR61","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s11046-017-0141-9","volume":"182","author":"LB Denardi","year":"2017","unstructured":"Denardi LB, et al. Activity of combined antifungal agents against multidrug-resistant Candida glabrata strains. Mycopathologia. 2017;182:819\u201328.","journal-title":"Mycopathologia"},{"key":"1878_CR62","doi-asserted-by":"publisher","first-page":"1397539","DOI":"10.3389\/fmed.2024.1397539","volume":"11","author":"Q Teng","year":"2014","unstructured":"Teng Q, et al. Case report: Successful combination therapy with isavuconazole and amphotericin B in treatment of disseminated Candida tropicalis infection. Front Med. 2014;11:1397539.","journal-title":"Front Med"},{"issue":"8","key":"1878_CR63","first-page":"859","volume":"55","author":"A Katragkou","year":"2017","unstructured":"Katragkou A, et al. In vitro combination therapy with isavuconazole against Candida spp. Med Mycol. 2017;55(8):859\u201368.","journal-title":"Med Mycol"},{"issue":"3","key":"1878_CR64","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41564-022-01083-2","volume":"7","author":"M France","year":"2022","unstructured":"France M, et al. Towards a deeper understanding of the vaginal microbiota. Nat Microbiol. 2022;7(3):367\u201378.","journal-title":"Nat Microbiol"},{"key":"1878_CR65","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1007\/s00203-021-02414-3","volume":"203","author":"VS Saraf","year":"2021","unstructured":"Saraf VS, et al. Vaginal microbiome: normalcy vs dysbiosis. Arch Microbiol. 2021;203:3793\u2013802.","journal-title":"Arch Microbiol"},{"issue":"12","key":"1878_CR66","doi-asserted-by":"publisher","first-page":"e1002478","DOI":"10.1371\/journal.pmed.1002478","volume":"14","author":"JH Van De Wijgert","year":"2017","unstructured":"Van De Wijgert JH. The vaginal microbiome and sexually transmitted infections are interlinked: consequences for treatment and prevention. PLoS Med. 2017;14(12):e1002478.","journal-title":"PLoS Med"},{"key":"1878_CR67","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3390\/healthcare9111555","volume":"9","author":"G Stabile","year":"2021","unstructured":"Stabile G, et al. New therapy for uncomplicated vulvovaginal candidiasis and its impact on vaginal flora. Healthcare. 2021;9:1555.","journal-title":"Healthcare"},{"key":"1878_CR68","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3390\/jof7070500","volume":"7","author":"ACM Caldeir\u00e3o","year":"2021","unstructured":"Caldeir\u00e3o ACM, et al. Nanocarriers of miconazole or fluconazole: effects on three-species Candida Biofilms and cytotoxic effects In Vitro. J Fungi. 2021;7:500.","journal-title":"J Fungi"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01878-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01878-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01878-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:02:43Z","timestamp":1763413363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01878-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":68,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1878"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01878-w","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"12 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}